Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ANKRD36B Inhibitors

ANKRD36B inhibitors are a class of chemical compounds specifically designed to target the ANKRD36B protein, which belongs to the family of ankyrin repeat domain-containing proteins. ANKRD36B contains multiple ankyrin repeat motifs, which are structural units known for their ability to mediate protein-protein interactions. These motifs consist of repeating helix-loop-helix structures that create stable surfaces for binding, enabling ANKRD36B to participate in a variety of cellular processes, such as signal transduction, protein trafficking, and cellular organization. ANKRD36B inhibitors work by interfering with these interactions, preventing ANKRD36B from forming or stabilizing the protein complexes it is involved in. This disruption affects the cellular mechanisms that depend on the structural integrity and functional role of ANKRD36B.

Chemically, ANKRD36B inhibitors exhibit a wide range of molecular structures, from small organic molecules to larger peptide-based constructs. These inhibitors are often designed to target specific sites within the ankyrin repeat domains, such as hydrophobic pockets or charged regions that are critical for binding to other proteins. Some ANKRD36B inhibitors act by mimicking the natural ligands of the protein, competing with endogenous binding partners for the same interaction sites. Others may induce conformational changes that destabilize the ankyrin repeat architecture, thereby preventing ANKRD36B from maintaining its functional conformation. By blocking the interaction networks mediated by ANKRD36B, these inhibitors serve as valuable tools for investigating the molecular mechanisms in which ANKRD36B is involved. They provide insights into how the protein's structural and regulatory roles contribute to larger cellular functions and processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent protein kinase inhibitor that can inhibit a wide range of kinases which may be involved in the phosphorylation state of ANKRD36B.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can alter phosphoinositide-dependent signaling, potentially affecting ANKRD36B's role in these pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor that can impact stress response pathways, possibly influencing ANKRD36B's function if it is stress-related.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that can affect protein degradation pathways, which may regulate the stability and turnover of ANKRD36B.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can alter gene expression patterns, potentially affecting ANKRD36B expression if it is epigenetically regulated.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can impact cell growth and proliferation, potentially influencing pathways where ANKRD36B is involved.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

A MEK inhibitor that can disrupt the MAPK/ERK signaling, potentially impacting ANKRD36B's function within this pathway.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can affect NF-κB signaling and cell cycle progression, possibly regulating ANKRD36B.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A MEK inhibitor that can inhibit the MAPK/ERK pathway, potentially affecting ANKRD36B's associated signaling processes.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which may impact stress and inflammatory response pathways that ANKRD36B could be part of.